Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 25.11.2019 | EN | Official Journal of the European Union | C 399/99 |

---

Action brought on 4 October 2019 – Health Product Group v EUIPO – Bioline Pharmaceutical (Enterosgel)

(Case T-678/19)

(2019/C 399/117)

Language of the case: English

Parties

Applicant: Health Product Group sp. z o.o. (Warsaw, Poland) (represented by: M. Kondrat, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Bioline Pharmaceutical AG (Baar, Switzerland)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: International registration designating the European Union in respect of the word mark Enterosgel – International registration designating the European Union No 896 788

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 8 August 2019 in Case R 482/2018-4

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision and cancel the trade mark; |

|  |  |
| --- | --- |
| — | award the costs in applicant’s favour. |

Plea in law

|  |  |
| --- | --- |
| — | Infringement of Article 59(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)